SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $18,535,000 | -20.9% | 1,891,328 | -12.8% | 2.06% | -15.1% |
| Q4 2016 | $23,426,000 | +29.2% | 2,169,043 | +22.6% | 2.43% | +11.2% |
| Q3 2016 | $18,138,000 | -21.5% | 1,769,558 | 0.0% | 2.19% | -12.7% |
| Q2 2016 | $23,110,000 | +3.7% | 1,769,558 | -12.6% | 2.50% | +9.3% |
| Q1 2016 | $22,277,000 | +323.4% | 2,025,150 | +254.1% | 2.29% | +234.1% |
| Q4 2015 | $5,261,000 | +345.5% | 571,887 | +236.0% | 0.69% | +328.8% |
| Q3 2015 | $1,181,000 | -88.7% | 170,218 | -84.0% | 0.16% | -89.6% |
| Q2 2015 | $10,444,000 | -22.6% | 1,063,520 | -30.2% | 1.53% | -31.7% |
| Q1 2015 | $13,490,000 | +10.8% | 1,522,625 | +9.6% | 2.24% | +31.4% |
| Q4 2014 | $12,172,000 | -5.5% | 1,389,525 | -25.7% | 1.71% | +8.0% |
| Q3 2014 | $12,887,000 | +33.2% | 1,870,367 | +1.7% | 1.58% | +11.2% |
| Q2 2014 | $9,676,000 | +20.7% | 1,839,628 | +4.4% | 1.42% | +10.5% |
| Q1 2014 | $8,017,000 | +3.6% | 1,762,051 | +14.8% | 1.29% | +2.6% |
| Q4 2013 | $7,737,000 | +61.2% | 1,535,201 | +62.1% | 1.26% | +16.7% |
| Q3 2013 | $4,801,000 | +4.3% | 946,948 | +2.0% | 1.08% | +0.8% |
| Q2 2013 | $4,604,000 | – | 928,209 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|